Hunan Hansen Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.7% in First Half of 2022

Hunan Hansen Pharmaceutical Co.,Ltd. (湖南汉森制药股份有限公司) (002412.SZ) reported a net profit of 78.9 million yuan in the first half of 2022, up 11.7% year-on-year.

Meanwhile, the company posted 462.7 million yuan in revenue, up 4.4% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 381.4 million yuan in total liabilities, with a liability-to-asset ratio of 17.3%.